GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 8:08 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $71.14. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $65.80. Eli Lilly& Co. fell$. 82 or 1.1 percent, to $71.58.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.12. Bristol-Myers Squibb Co. fell$. 28 or. 4 percent, to $65.72. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.42.

  • Early Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 10:55 AM ET

    Baxter International Inc. fell$. 42 or. 6 percent, to $71.09. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $65.89. Pfizer fell$. 11 or. 3 percent, to $35.25.

  • Final Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Baxter International Inc. rose $1.13 or 1.6 percent, to $71.51. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $66.00. Eli Lilly& Co. rose$. 10 or. 1 percent, to $72.40.

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 1:24 PM ET

    Baxter International Inc. rose $1.67 or 2.4 percent, to $72.05. Bristol-Myers Squibb Co. fell$. 54 or. 8 percent, to $66.06. Eli Lilly& Co. rose$. 25 or. 3 percent, to $72.55.

  • Early Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 11:02 AM ET

    Baxter International Inc. rose $1.00 or 1.4 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 63 or. 9 percent, to $65.97. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.32.

  • April 23- A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells. The partnership between AstraZeneca's research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as...

  • April 23- Eli Lilly and Co soundly beat quarterly profit estimates on lower-than-expected spending on research and marketing but stuck to its full-year earnings forecast while revenue fell but matched expectations. Lilly earned $530 million, or 50 cents per share, in the quarter, compared with $728 million, or 68 cents per share, a year earlier..

  • The Indianapolis- based drugmaker posted a net profit of $529.5 million, or 50 cents per share, for the first quarter ended March 31, compared with a profit of $727.9 million, or 68 cents per share, a year earlier. In January, the company forecast full-year adjusted earnings of $3.10- $3.20 per share, and sales of $19.50- $20 billion. Lilly on Thursday cut its full-year...

  • INDIANAPOLIS— Eli Lilly and Co.' s first-quarter earnings tumbled 27 percent as generic competition continued to eat away at sales for key products, but the drugmaker's performance topped expectations. Overall, Lilly earned $529.5 million, or 50 cents per share, in the quarter that ended March 31. Analysts forecast, on average, earnings of 76 cents per share,...

  • Lilly profit falls 27 percent, hurt by strong dollar Thursday, 23 Apr 2015 | 6:32 AM ET

    April 23- Eli Lilly and Co reported a 27 percent fall in quarterly profit, hurt by a stronger dollar. The Indianapolis- based drugmaker posted a net profit of $529.5 million, or 50 cents per share, for the first quarter ended March 31, compared with a profit of $727.9 million, or 68 cents per share, a year earlier. Excluding items, the company earned 87 cents per share.

  • FRANKFURT, Germany— Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies. Novartis sold its animal health business to Lilly. It also bought cancer drugs from GSK and sold its non-flu vaccines business, while Novartis and GSK combined their...

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $70.38. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Hospira rose$. 04 or percent, to $87.80.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $69.93. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Eli Lilly& Co. fell$. 02 or percent, to $72.19.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $66.70. Eli Lilly& Co. rose$. 09 or. 1 percent, to $72.30.

  • LONDON, April 22- Swiss drugmaker Roche has "renewed confidence" that drugs targeting potentially brain-destroying plaque can fight Alzheimer's disease, following promising results with a product from a rival. Pharmaceuticals head Daniel O'Day said on Wednesday Roche would look again at prospects for two of its experimental Alzheimer's drugs, both of...

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Bristol-Myers Squibb Co. rose$. 95 or 1.4 percent, to $66.81. Eli Lilly& Co. fell$. 20 or. 3 percent, to $72.21.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 1:45 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $70.05. Bristol-Myers Squibb Co. rose$. 82 or 1.2 percent, to $66.68. Hospira fell$. 03 or percent, to $87.81.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Apr 2015 | 10:52 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $70.00. Bristol-Myers Squibb Co. rose$. 67 or 1.0 percent, to $66.53. Eli Lilly& Co. rose$. 27 or. 4 percent, to $72.68.

  • Final Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 7:11 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $70.36. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $65.86. Eli Lilly& Co. fell$. 06 or. 1 percent, to $72.41.